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Background: Successful repair of the ruptured (non-traumatic) descending thoracic aorta (rTA) remains a formidable
clinical challenge. Although effective for rTA, traditional open repair (DTAR) has significant associated morbidity. With
expanding indications for thoracic endovascular aortic repair (TEVAR), we describe our experience with TEVAR and
DTAR in this high-risk setting to elucidate their evolving roles.
Methods: Since the inception of our thoracic aortic endovascular program in 1993, 69 patients underwent DTAR (34) or
TEVAR (35) for rTA. Patients underwent TEVAR if they were considered nonoperative candidates because of extensive
comorbidities (n  31; 88.6%) or had extremely favorable anatomy for endovascular repair (eg, mid-descending saccular
aneurysm, n  4). Aortic pathology causing rupture was fusiform aneurysm (18), saccular aneurysm/ulcer (22), and
dissection (29). Associated aortobronchial fistulae (12) and aortoesophageal (1) fistulae were also present in 18.8%. Arch
repair was needed in 46; total descending repair was needed in 33. Follow-up was 100% complete (mean 37.4 months).
Results:Mean age was 65.9 years (DTAR 60.3 year vs TEVAR 71.3 years, P .005). In-hospital or 30-day mortality was
seen in 13 patients (TEVAR n  4; 11.4% vs DTAR n  9; 26.5%, P  .13). Median length of stay was shorter after
TEVAR (8 days vs DTAR 15 days, P  .02). Mean Kaplan-Meier survival was similar between groups (TEVAR 67.4
months vs DTAR 65.0 months, P .7). By multivariate analysis, independent predictors of a composite outcome of early
mortality, stroke, permanent spinal cord ischemia, or need for dialysis or tracheostomy included the presentation with
hemodynamic instability (P < .001) and treatment with conventional open repair (P  .02).
Conclusion: An endovascular approach for the ruptured (non-traumatic) descending thoracic aorta reduces early
morbidity, mortality, and duration of hospitalization, while providing equivalent late outcomes even in an older group
largely considered high risk for open repair. These data support a paradigm shift, with TEVAR emerging as the preferred
therapy for all patients presenting with descending aortic rupture. ( J Vasc Surg 2009;50:1265-70.)The gold standard therapy for descending thoracic
aneurysms has traditionally been open repair (DTAR).
However, recent work by our group as well as others has
suggested that high-risk patients, whether related to co-
morbidities or presentation, may be more appropriately
treated with an endoluminal approach (TEVAR).1-3 Re-
ported outcomes following DTAR for the non-traumatic
ruptured thoracic aorta have been poor, with docu-
mented mortality rates exceeding 20%.4-6 Although
comparative analyses of open and endovascular thoracic
aortic repair have been conducted in the elective setting
or for subgroups of patients with thoracic aortic pathol-
ogy, no report thus far has concurrently compared out-
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doi:10.1016/j.jvs.2009.07.091comes in the setting of the non-traumatic ruptured
descending aorta.7 The purpose of this study is to focus
on these outcomes.
METHODS
This study was approved by the Institutional Review
Board (IRB) of the University of Michigan Hospitals (IRB
#2003-0128, informed consent requirements waived).
Data from all patients (n  69) who underwent oper-
ative therapy for ruptured descending thoracic aortic pa-
thology (excluding blunt traumatic aortic injury) at the
University of Michigan Hospitals between 1993 and Feb-
ruary 2009 were prospectively collected and retrospectively
analyzed. The anatomic extent of pathology requiring in-
tervention in all instances was located between the left
carotid artery and the celiac axis. Patients presenting with
thoracoabdominal aneurysm rupture were excluded from
this analysis. The diagnosis of a ruptured aorta was made by
computed tomography (CT) demonstration of contrast
extravasation outside the aorta (uncommon) or (more
common) by aneurysmal enlargement of the aorta with
high-attenuation crescents in thickened wall (crescent
sign), soft-tissue infiltration of peri-aortic fat, and inability
to define the outer wall of the aorta (peri-aortic hematoma)
and/or pseudoaneurysm formation. For those patients un-
dergoing open aneurysm repair, the intraoperative findings
of rupture were confirmed. All patients were evaluated for
open repair initially by a surgeon with specific expertise in
thoracic aortic reconstruction. Patients who were prospec-
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repair (n  31) or had extremely favorable anatomy for
endovascular repair (eg, mid-descending saccular aneu-
rysm, n  4) underwent TEVAR as previously described.2
High-risk comorbidities identified in this group included
prior history of myocardial infarction, renal failure, stroke,
malignancy, or chronic obstructive pulmonary disease
(COPD), or poor preoperative functional status.
All open thoracic aortic repairs (n  34) were per-
formed with extracorporeal perfusion support. Left heart
bypass or partial cardiopulmonary bypass was utilized in
eight patients. The remaining 26 patients had adjunctive
use of deep hypothermic circulatory arrest (HCA) as previ-
ously described.8 Indications for HCA included the pres-
ence of aortic pathology precluding use of aortic cross
clamp, or the need to extend the resection into either the
arch aorta or the entire descending thoracic aorta.
Postoperative management for prevention of spinal
cord ischemia for both open and endovascular repairs was
conducted according to standardized protocols as previ-
ously described.3 Assuming hemodynamic stability allow-
ing placement of lumbar drains, both groups of patients
received spinal drainage at the discretion of the surgeon for
similar indications and included those patients needing
repair beyond the proximal third of the descending aorta or
in the distal half of the descending aorta. Those patients
with previous infrarenal aortic repair also preferentially had
placement of lumbar drains. In total, 20 patients under-
went placement of lumbar drains (DTAR n 12, 35.3% vs
Table I. Demographics and comorbidities with univariate
Open re
Demographics
Age (years) 60
Male gender 24
Mean aortic dimension (cm) 6
Comorbidities
CAD 7
History of CHF 2
COPD 4
Diabetes 4
Hypertension 24
Preoperative creatinine (mg/dL) 1
Prior AAA repair 4
PVOD 10
History of tobacco abuse 16
High risk from comorbidities 2
Aortic pathology causing rupture
Hemodynamic instability at presentation 3
Fusiform aneurysm 8
Acute aortic dissection 18
Saccular aneurysm/pseudoaneurysm 8
Aortic fistulae 6
Treated aortic segments*
Arch aorta 27
Total descending aorta 17
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; CHF, c
peripheral vascular occlusive disease; TEVAR, thoracic endovascular aortic
*Not mutually exclusive. Treatment of both arch and total descending aortTEVAR n  8, 22.9%).The primary outcomes of this study were: 1) a compos-
ite outcome of early (in-hospital or 30-day) mortality,
stroke, permanent spinal cord ischemia, need for dialysis, or
prolonged ventilatory support requiring tracheostomy; and
2) vital status at last follow-up. Data were collected from
clinic visit notes, hospital charts, and imaging studies, and
mortality was verified by interrogation of the National
Death Index. Follow-up for these primary outcomes was
100% complete as of February 2009 (mean follow-up 37.4
41.3 months).
Statistical analysis. Data were analyzed using SPSS
(SPSS Inc., Chicago Ill). Dichotomous variables were eval-
uated using chi-square analysis; continuous variables were
evaluated using one-way analysis of variance. Multivariate
models (binary logistic regression) were constructed using a
forwardconditional process to identify factors thatwere indepen-
dently associated with each of the outcomes of interest. Mod-
els were tested for goodness of fit using the Hosmer-Leme-
show statistic. Factors utilized inmultivariate analysis included
using those with P  .1 significance on univariate analysis.
Survival was analyzed by Kaplan-Meier methods. All results
with P .05 were considered statistically significant.
RESULTS
The mean age of the entire cohort was 65.7  16.5
years (59.4% male). Demographics and comorbidities for
the two groups are listed in Table I. The DTAR group was
younger, had larger aortic diameters, had a lower frequency
ysis of the study groups
(n  34) TEVAR (n  35) P value
14.2 71.3  16.9 0.005
5%) 17 (48.6%) 0.087
2.0 5.6  2.0 0.04
6%) 11 (31.4%) 0.41
%) 0 (0%) 0.24
7%) 13 (37.1%) 0.02
7%) 4 (11.4%) 1.0
5%) 27 (32.6%) 0.59
0.5 1.0  0.6 0.85
7%) 5 (14.3%) 1.0
4%) 13 (37.1%) 0.61
1%) 21 (60%) 0.34
%) 31 (88.6%) 0.001
%) 3 (8.6%) 1.0
6%) 10 (28.6%) 0.79
9%) 11 (31.4%) 0.09
6%) 14 (40%) 0.2
6%) 7 (20%) 1.0
4%) 19 (54.3%) 0.04
) 16 (45.7%) 0.8
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of repair, and procedural details are also listed in Table I.
Technical success in TEVAR was achieved in 33 pa-
tients (94.3%). The remaining two patients presented with
contained ruptures. One had a slow-filling proximal type 1
endoleak in a highly curved arch and the other had a
slow-filling distal type 1 endoleak with a marginal distal
neck at the celiac axis. Neither patient was deemed an open
operative candidate; both were lost to imaging follow-up
after discharge and survived 53 and 2.5 months, respectively.
Devices utilized included Gore TAG (WL Gore and Associ-
ates, Flagstaff, Ariz) (19), Medtronic Talent (Medtronic, Inc,
Minneapolis, Minn) (9), custom fabricated (3), AneuRx aor-
tic cuff (Medtronic, Inc) (3) and Cook TX2 (Cook Inc,
Bloomington, Ind) (1). Device delivery was via a transfemoral
approach in 27, an iliac approach utilizing a conduit in five,
and ascending aorta and carotid artery in one each. Of
the 19 patients who had coverage of the left subclavian
artery, 10 underwent left carotid-subclavian bypass prior to
TEVAR.
Early results. Understanding baseline differences in
this cohort, there was a trend toward a reduction in early
mortality (defined as either in-hospital or within 30 days) in
the TEVAR group (n  4; 11.4% vs DTAR n  9; 26.5%,
P .13). The causes of early mortality are listed in Table II.
The only univariate correlate of this outcome was the
presentation with hemodynamic instability (P  .0001).
The incidence of stroke was 2.9% (n 2). Both patients
had undergone open resection of the distal arch aorta for
contained ruptures, one with the use of hypothermic arrest.
This latter patient had a protracted postoperative course
requiring temporary dialysis and tracheostomy but was
ultimately discharged on postoperative day 88. The other
Table II. Cause of in-hospital or 30-day mortality
Patient Thoracic aortic pathology
DTAR group
1 Saccular aneurysm
2 Aortic dissection
3 Saccular aneurysm
4 Aortic dissection
5 Aortic dissection
6 Aortobronchial fistula, saccular aneurysm
7 Hemodynamically unstable, fusiform aneurysm
8 Hemodynamically unstable, acute dissection
9 Hemodynamically unstable, acute on chronic
dissection
TEVAR group
1 Rupture at aberrant right subclavian artery
2 Hemodynamically unstable, penetrating ulcer/
intramural hematoma
3 Hemodynamically unstable, aortobronchial
fistula from post-coarctation
pseudoaneurysm
4 Aorto-esophageal fistula from saccular
aneurysm
DTAR, Open descending thoracic aneurysm repair; POD, post-operative d
*Withdrawal of care.patient, who had aortic resection using partial cardiopul-monary bypass for a ruptured pseudoaneurysm with aorto-
bronchial fistula, sustained a brainstem stroke. He had no
neurological recovery, and care was withdrawn on postop-
erative day four. The incidence of renal failure needing
dialysis was seen in 10 patients (14.5%), with no significant
difference found between groups (P  .19).
Permanent lower extremity paralysis or paresis was seen
in one patient (1.4%) who had undergone open repair of
the distal arch and total descending aorta for an acute on
chronic dissection with contained rupture (with lumbar
drain). This patient developed a compartment syndrome in
the left leg (site of femoral artery cannulation). He had a
protracted postoperative course and returned to the oper-
ating room for muscle debridement on postoperative day
10. He had several bouts of hypotension during this pro-
cedure and awoke thereafter with lower extremity paralysis.
Despite re-insertion of a lumbar drain and permissive hy-
pertension, he never recovered his spinal cord function.
In order to generate a sufficient event rate for multivar-
iate analysis, a composite end-point representing this early
morbidity and mortality (early death, stroke, permanent
paraplegia, a need for dialysis or tracheostomy) was derived.
Univariate correlates with this outcome measure are listed
in Table III. Independent predictors of this poor composite
end-point included presentation with hemodynamic insta-
bility (P  .001) and repair with a conventional open
approach (P .02). Surprisingly, the pathology underlying
the rupture did not correlate on univariate analysis with the
risk for a poor composite outcome (all P .24). Finally, the
TEVAR group had a significantly shorter postoperative
length of stay (median TEVAR 8 days vs DTAR 15 days,
P  .02).
Late results. The overall crude mortality rate for the
Cause of mortality
inant pneumonia. death on POD #35*
rior mesenteric artery embolus, death from sepsis POD #4
operative death from cardiogenic shock
operative death from cardiogenic shock
grade type A dissection, death POD #2*
stem infarct, death POD #4*
h from multisystem organ failure on POD #8
isystem organ failure, death on first operative day
operative death, unable to separate from cardiopulmonary bypass
operative death from iliac artery rupture
ured thoracic aorta on night of TEVAR
h from hypoxemia and multisystem organ failure on POD#2
h from development of tracheo-esophageal fistula on POD #23
VAR, thoracic endovascular aortic repair.Fulm
Supe
Intra
Intra
Retro
Brain
Deat
Mult
Intra
Intra
Rupt
Deat
Deatentire cohort at last follow-up was 50.7% and did not differ
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.81). Univariate correlates of late mortality are included in
Table III. Independent predictors of late mortality in-
cluded age (P .017) and presentation with hemodynamic
instability (P  .0001). By Kaplan-Meier analysis (Fig 1),
actuarial survival was also similar between open and endo-
vascular groups (P  .72).
Endoleaks were seen in nine patients (25.7%), and
Table III. Univariate analysis of early and late
outcomes*
P value
Univariate correlates of early poor composite
outcome
Age .04
COPD .02
Group considered high risk for open repair
secondary to comorbid conditions .07
Hemodynamic instability at presentation  .0001
Treatment group .04
Univariate correlates of late mortality
Age .12
Need for arch repair .04
Acute dissection pathology .09
Presence of aortic fistulae or mycotic
aneurysm .06
Hemodynamic instability at presentation .03
COPD, Chronic obstructive pulmonary disease.
*All variables in this table were used for both subsequent multivariate
analysis to identify independent risk factors for early poor composite out-
come and late mortality.
Fig 1. AKaplan-Meier survival analysis comparing open descend-
ing thoracic aortic repair to thoracic aortic endovascular repair.
This actuarial analysis demonstrates that following either open or
endovascular thoracic aortic repair, there is no significant differ-
ence in Kaplan-Meier survival for patients presenting with de-
scending aortic rupture. The 10-year survival for TEVAR is 21.3%
vs that for DTAR at 30.8% (log rank P .72). The survival curves
have been truncated at seven years, where the standard error
exceeds 10%.included type 1 (3), type 2 (2), type 3 (2), and indetermi-nant type (2). Two of those with type 1 endoleaks required
open repair but were not treated, as they were not consid-
ered open operative candidates. One expired of aortic rup-
ture at 39 months, and the other died of unknown cause at
13 months. The remaining patient underwent a successful
proximal extension. One patient with a type 3 endoleak was
successfully treated during the same hospitalization as the
primary procedure. Another patient who had presented
with an aortobronchial fistula had an early type 3 endoleak,
refused therapy, and expired in hospice at four months.
Finally, one with a type 2 endoleak underwent successful
coil embolization of the left subclavian artery, while the
other patient was observed, and had a stable sac size at last
follow-up. There were no instances of migration identified.
A Kaplan-Meier curve, shown in Fig 2, was constructed to
examine the risk for aortic reintervention at four years in
any aortic segment, including treated, adjacent, or remote
segments. This analysis suggested a higher need for aortic
reintervention in the TEVAR group.
DISCUSSION
Thoracic aortic rupture remains a formidable clinical
entity. A population-based study from Sweden suggested
that presentation with thoracic aortic rupture (including
ascending, arch and descending aorta) was associated with
a mortality rate of 54% in the first six hours following onset
of symptoms.9 Therapy in this setting has traditionally been
considered open repair. Despite improvements in periop-
erative care, outcomes following open repair of the rup-
Fig 2. A Kaplan-Meier analysis describing the need for reinter-
vention in any aortic segment. This analysis suggests that the need
for aortic reintervention at any aortic segment (treated, adjacent,
or remote) is significantly higher in the TEVAR group. Freedom
from reintervention at four years was 87.4% for DTAR vs 61.2% for
TEVAR (P .037). In this analysis, if patients were deemed to be
nonoperative, or refused further intervention, the date at which
point the need for reintervention was identified was used as the
time of treatment failure.tured descending thoracic aorta remain poor and ill de-
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describe these outcomes, they have been confounded with
inclusion of thoracoabdominal aortic pathology. These
studies have suggested that early mortality rates, variably
reported as in-hospital or 30-day, range from 20% to 50%
following open repair. Rates of spinal cord ischemia, myo-
cardial infarction, and renal failure are also significantly
elevated, when compared with that obtained with elective
repair.
With the advent of an endovascular solution for de-
scending thoracic aortic pathology, several investigators
have reported successful outcomes with TEVAR for the
ruptured aorta.10-12 Scheinert and colleagues reported an
early mortality rate of 9.7% with TEVAR for rupture in 31
patients.10 Recent comparative series have included a re-
port from Morishita et al describing mortality rates that
were slightly higher in the stent grafted group (17% vs
DTAR 9%) in 29 patients.11 In contrast, Doss et al, in
another comparative analysis in 60 patients, reported a
reduced early mortality in the endovascular arm (3.1%) vs
open group (17.8%).12 They suggested that late complica-
tions including need for reintervention were higher in the
TEVAR group, and that continued surveillance was neces-
sary. However, these and other reports have included pa-
tients presenting with traumatic aortic rupture. The addi-
tion of blunt aortic trauma in an appraisal of aortic rupture
may not be valid, as there have been multiple reports
describing the initial successful non-operative treatment for
blunt aortic trauma.13 This suggests that the natural history
of patients with untreated non-traumatic and traumatic
ruptures may be quite different, with the latter group
having a more benign course.9,13
The current analysis focuses on patients with non-
traumatic rupture, and describes a 15-year comparison of
open and endovascular repair in this setting. Both groups
were not directly comparable, with the endovascular group
presenting at an advanced age, less frequently needing arch
repair and more frequently designated as high-risk open
operative candidates. Despite these differences, TEVAR in
this setting was independently predictive of an improved
early outcome as defined by a composite endpoint of early
death, stroke, paraplegia, or need for dialysis or tracheos-
tomy. Importantly, late survival was not significantly differ-
ent between groups, although the risk for aortic reinterven-
tion was higher after TEVAR.
The rates of mortality in this series do not differ from
other published reports.4-6,10-12 However, they are mark-
edly different than those obtained with elective aneurysm
repair, highlighting the importance of early detection. Typ-
ically, the decision to proceed with aneurysm repair is
predicated on the ratio of the risk of rupture or dissection to
the risk of repair, with the absolute aortic diameter as the
most important determinant of rupture.14 It is interesting
to note that the mean diameter at the time of rupture in this
series was 6.2 cm, not significantly greater than the typical
size criterion for intervention for descending aortic pathol-
ogy (6.0 cm). This suggests that with the perceived reduc-
tion in morbidity and mortality with an endovascular ap-proach, a randomized trial of intervention vs standard
medical therapy for smaller thoracic aneurysms (ie, 5.0 to
6.0 cm) is now warranted.
At the University of Michigan, patients with elective
indications for intervention are evaluated for TEVAR on a
selective basis, with younger age ( 65 years), physiologic
status of the patient, and anatomic suitability for TEVAR
deemed among the most important criteria for a recom-
mendation to proceed with open repair. In contrast, for
patients presenting with rupture, we now preferentially
evaluate all patients for an endovascular approach regard-
less of age. Specific exclusion criteria for TEVAR in this
setting include the presence of rupture in a pre-existing
chronic dissection or in patients with connective tissue
disease, lack of access vessels for delivery, or the presence of
compromised landing zones. The latter is a relative contra-
indication for TEVAR, however, as compromised landing
zones may occasionally be used in patients not considered
suitable for open operation.
Although open repair is still considered the gold stan-
dard therapy, the need for urgent or emergent intervention
in the setting of rupture may preclude a full appraisal of
comorbidities, particularly a cardiac evaluation. With the
significant additional physiological stress of open repair (vs
TEVAR), it is not surprising that two of the nine DTAR
deaths were cardiac related (vs none for TEVAR). This has
also been identified as a cause of mortality in up to 75% of
patients in other reports of DTAR in rupture.4,5 Under-
standing the exceedingly poor prognosis with a postopera-
tive myocardial infarction, we now consider performance of
a cardiac catheterization immediately prior to open repair.
This delay is undertaken only in selected patients with a
significant prior cardiac history (ie, previous myocardial
infarction with reduced ejection fraction, or active cardiac
symptoms). These patients must also present with stable
hemodynamics with a contained rupture and must also be
anatomically unsuitable for TEVAR. If they are found to
have significant coronary artery disease, we perform open
repair with simultaneous coronary artery bypass graft
(CABG), consider percutaneous angioplasty without stent-
ing of the target coronary artery (ie, no clopidogrel require-
ment), or deem them to be too high risk for open surgery.
One patient in this report underwent a DTAR with con-
comitant CABG for left main disease. He succumbed to a
retrograde type A dissection on the second postoperative
day; the family refused further intervention and withdrew
care. In contrast, for those patients who are to undergo
TEVAR, cardiac evaluation is only undertaken if: 1) these
patients are not considered open operative candidates; 2) if
they are hemodynamically stable and have a contained
rupture; and 3) if they have a significant prior cardiac
history. Cardiac evaluation in this setting consists of a
nuclear stress test. TEVAR is then performed urgently if no
contraindication exists. If a significant cardiac ischemic
burden is identified, we then decide whether to perform
angioplasty without stenting of the coronary artery with
TEVAR thereafter, perform CABG, and deliver the en-
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deem them unsuitable for endovascular repair.
Limitations of this study include its retrospective na-
ture, small sample size, and baseline differences between
groups. Indeed, the differences in these groups primarily
reflect a selection bias preferentially shunting older patients
with more complex comorbidities to the TEVAR arm.
Despite this, we were able to identify the importance of a
TEVAR strategy in reducing early morbidity even in this
older and higher-risk group. However, baseline differences
in pathologic extent (ie, more frequent arch repair in
DTAR) may also have contributed to the increased mor-
bidity seen in the open repair group. Another important
limitation is that although the study spans the entire
TEVAR era at the University of Michigan, access to the
endovascular arm in this retrospective analysis varied by
date of operation (Fig 3). The TEVAR “learning curve”
likely affected who were considered suitable anatomic can-
didates (including proportion of open repair patients ana-
tomically eligible for TEVAR), and the availability of en-
dografts at our institution was markedly different after the
FDA approval of the Gore TAG device in 2005.
In conclusion, presentation with a ruptured descending
aorta portends a poor prognosis for early and late survival.
This comparative analysis of open and endovascular strate-
gies for the ruptured (non-traumatic) aorta suggests that
TEVAR reduces early morbidity while yielding equivalent
Fig 3. The evolution of therapy for descending aortic rupture at
the University of Michigan. This graph divides the entire TEVAR
era at the University ofMichigan into three time periods. The years
1993-1999 reflect the time when no commercial endografts were
generally available, and the dominant procedure is open aortic
repair. During the years 2000-2004, endografts were typically
available as part of clinical trials, although we did selectively utilize
custom-fabricated devices. Finally, 2005-2008 reflects the time
period when thoracic endografts were commercially available. This
graph demonstrates an increasing shift toward endovascular repair
during the study period, likely reflecting the ability to now offer a
therapeutic option to patients previously considered non-operative
candidates (ie, previously referred to medical therapy alone). Note,
however, during this period, open repair is still considered an
important option during this period, representing the primary
mode of therapy for patients considered suitable candidates for
open repair.late survival even in a group largely considered high risk foropen surgery. These results support a paradigm shift, with
TEVAR emerging as the therapy of choice for all patients
presenting with descending aortic rupture.
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